Screening for tardive dyskinesia involves asking about movement changes and observing relevant body regions. Clinicians may use a structured tool such as the Abnormal Involuntary Movement Scale to document findings and follow change. A scale supports consistent assessment but does not replace diagnosis or the person’s account of impact.<\/p>\n
Tardive dyskinesia is a movement disorder associated with exposure to dopamine receptor-blocking medicines. It often develops after ongoing treatment, although patterns vary. Movements can persist and may affect function or wellbeing. It differs from acute dystonia, akathisia and drug-induced parkinsonism, making accurate assessment important rather than treating all movement changes as one problem.<\/p>\n
Baseline observations and periodic review can make subtle changes easier to recognise. Timing depends on clinical circumstances and local guidance. The person should be able to report embarrassment, discomfort or difficulties with eating and speaking without feeling blamed. Screening also considers dental status, other movement disorders and medicines outside psychiatry. A brief normal examination does not necessarily exclude intermittent symptoms. The purpose is early recognition and an informed management discussion, not simply completing a score that is filed without explanation or follow-up when a concern is identified.<\/p>\n
The Abnormal Involuntary Movement Scale records movement severity across body regions and includes wider clinical observations. It is useful for tracking but is not a stand-alone test of causation. Repeated measures and discussion of impact can show change over time. A score should support an informed response, with findings explained rather than left as an unexplained number in the record.<\/p>\n
Further reading:<\/strong> National Institute of Mental Health<\/a>; DailyMed prescribing information<\/a>; US FDA medicine information<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":" Screening for tardive dyskinesia involves asking about movement changes and observing relevant body regions. Clinicians may use a structured tool such as the Abnormal Involuntary Movement Scale to document findings and follow change. A scale\u2026Continue Reading<\/a><\/span><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48],"tags":[51],"class_list":["entry","author-","has-excerpt","post-749","post","type-post","status-publish","format-standard","category-medication-effects","tag-tardive-dyskinesia"],"brizy_media":[],"_links":{"self":[{"href":"https:\/\/schizophrenia.world\/index.php?rest_route=\/wp\/v2\/posts\/749","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/schizophrenia.world\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/schizophrenia.world\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/schizophrenia.world\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=749"}],"version-history":[{"count":0,"href":"https:\/\/schizophrenia.world\/index.php?rest_route=\/wp\/v2\/posts\/749\/revisions"}],"wp:attachment":[{"href":"https:\/\/schizophrenia.world\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=749"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/schizophrenia.world\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=749"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/schizophrenia.world\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=749"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}